Product Information

OSELTAMIVIR 6 MG/ML SUSPENSION is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.1511 per ML under NDC 00093818064. Its NADAC has been published 363 times since Sep 11, 2019.

FDA first approved this application on Feb 27, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

OSELTAMIVIR 6 MG/ML SUSPENSION

Oseltamivir Phosphate
$0.1511per ML

Strength

6 mg/mL

NDC

00093818064

Classification

Generic

Dosage Form

POWDER, FOR SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

OSELTAMIVIR PHOSPHATE

Approval Type

Generic (ANDA)

FDA Application

ANDA211125

FDA Approved

2/27/2019

TE Code

AB

On Market Since

7/10/2019

Pharmacological Classes

Neuraminidase Inhibitor
Neuraminidase Inhibitors

Price Statistics

The NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has been published 363 times since Sep 11, 2019, and over the history we have for it it has declined 81.9%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1511 per ML
All-time high$0.8870 (Nov 13, 2019)
All-time low$0.1271 (Nov 20, 2024)
52-week high$0.1739
52-week low$0.1497
Median price$0.3754
Average price$0.3774
Largest weekly change-56.9% (Sep 20, 2023)
Weeks tracked363
Tracking sinceSep 11, 2019

Price History

1W

-1.3%

1M

-1.3%

3M

-4.0%

6M

-0.5%

1Y

-11.1%

3Y

-64.8%

5Y

-60.1%

All

-81.9%

Generic Alternatives

The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of OSELTAMIVIR 6 MG/ML SUSPENSION?

The current National Average Drug Acquisition Cost (NADAC) for OSELTAMIVIR 6 MG/ML SUSPENSION, manufactured by Teva Pharmaceuticals USA Inc., is $0.1511 per ML (NDC 00093818064), effective Aug 19, 2026.

How has the price of OSELTAMIVIR 6 MG/ML SUSPENSION changed over time?

Over the history we have for it, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has declined 81.9%. It has been tracked across 363 weekly CMS publications since Sep 11, 2019.

What are the highest and lowest recorded NADAC prices for OSELTAMIVIR 6 MG/ML SUSPENSION?

Since Sep 11, 2019, the NADAC for OSELTAMIVIR 6 MG/ML SUSPENSION has ranged from a low of $0.1271 (Nov 20, 2024) to a high of $0.8870 (Nov 13, 2019), with a median of $0.3754 per ML.

Are there cheaper alternatives to OSELTAMIVIR 6 MG/ML SUSPENSION?

4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as OSELTAMIVIR 6 MG/ML SUSPENSION in a comparable dosage form, but none are currently priced below it.

Who manufactures OSELTAMIVIR 6 MG/ML SUSPENSION?

OSELTAMIVIR 6 MG/ML SUSPENSION (NDC 00093818064) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.